Martin Guggenberger

Publications by Year

Research Areas

Estrogen and related hormone effects, Breast Cancer Treatment Studies, Complementary and Alternative Medicine Studies, Advanced Breast Cancer Therapies, BRCA gene mutations in cancer

Most-Cited Works

• → Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: Results of the prospective EvAluate-TM study(2018)45 cited
• → Influence of patient and tumor characteristics on early therapy persistence with letrozole in postmenopausal women with early breast cancer: results of the prospective Evaluate-TM study with 3941 patients(2017)44 cited
• → Interest in Integrative Medicine Among Postmenopausal Hormone Receptor–Positive Breast Cancer Patients in the EvAluate-TM Study(2016)28 cited
• → Evaluation of Therapy Management and Patient Compliance in Postmenopausal Patients with Hormone Receptor-positive Breast Cancer Receiving Letrozole Treatment: The EvaluateTM Study(2014)14 cited
• → Delegation of strategic decision-making authority to middle managers(2015)9 cited
• → Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study(2019)8 cited
• → Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study(2016)7 cited
• [40-year-old patient without previous illness with acute shock symptoms and disseminated intravascular coagulation].(1996)
• → Interest in integrative medicine among postmenopausal hormone receptor-positive breast cancer patients receiving letrozole treatment in the EvAluate-TM study(2016)1 cited
• → PharmaNews(2016)1 cited